News and Views
Nature Biotechnology 25, 994 - 996 (2007)
doi:10.1038/nbt0907-994
On the iTRAQ of kinase inhibitors
Forest M White1
- Forest M. White is in the Biological Engineering Department and Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA. e-mail: fwhite@mit.edu
Abstract
Cellular targets of kinase inhibitors are identified by mass spectrometric analysis of binding to "kinobeads."
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsNature Biotechnology Research (01 Sep 2007)
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cellsLeukemia Original Article
